BridgeMD
Tests treatment safety and results for Oligospermia
Official title Efficacy and Safety Study of Products Based on Tribulus Terrestris, L. in Men With Oligospermia
ClinicalTrials.gov ID: NCT06260007
What this study is testing
What is Tribulus terrestris?
Tribulus terrestris is an investigational medicine, being studied as a potential treatment for oligospermia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Efficacy and Safety of Products Based on Tribulus terrestris, L. in Men with Oligospermia.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 60, men only
You may be able to join if
- \- Male;
- \- Ages 25 and 60;
- \- Diagnosis of oligospermia;
- \- With sexual partner;
- \- Indication of drug treatment with steroid hormones, precursors or analogues.
You likely can't join if
- \- Severe oligospermia
- \- Anatomical change
- \- Previous treatment for oligospermia or concomitant treatment with steroid, anabolic, hormonal precursors such as testosterone or analogues;
- \- BMI 35;
- \- Participant who presents liver enzyme and creatinine values above the upper limit of normality;
- \- History of testicular cancer, or prostate cancer or any other condition that carries risks in this case increased testosterone;
See the full eligibility criteria
- \- Male;
- \- Ages 25 and 60;
- \- Diagnosis of oligospermia;
- \- With sexual partner;
- \- Indication of drug treatment with steroid hormones, precursors or analogues.
- \- Severe oligospermia
- \- Anatomical change
- \- Previous treatment for oligospermia or concomitant treatment with steroid, anabolic, hormonal precursors such as testosterone or analogues;
- \- BMI 35;
- \- Participant who presents liver enzyme and creatinine values above the upper limit of normality;
- \- History of testicular cancer, or prostate cancer or any other condition that carries risks in this case increased testosterone;
- \- Hypersensitivity to any ingredient present in the formulation;
- \- Any criteria or clinical history that, in the investigator's opinion, could compromise the well-being and participant safety;
- \- Proven infertility of the partner;
- \- History of genetic disorder;
- \- History of psychiatric disorder, serious or decompensated illness or any situation that, Investigator's discretion, puts the participant's safety at risk;
- \- Active cancer at the discretion of the Investigator;
- \- Participants with pregnant and breastfeeding partners;
- \- Cycling and horse riding more than 3 hours per week;
- \- Alcoholism characterized by the inability to control alcohol consumption according to WHO "drinker excessive, whose dependence on alcohol is accompanied by mental, health and physics, relationships with others and...
- \- Smoking greater than half a pack per day or equivalent.
The study team makes the final eligibility decision.
Where it's taking place
- Valinhos, São Paulo, Brazil
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 25 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valinhos, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.